Sale!

TRANESMA PLUS TABLET

Original price was: ₹650.00.Current price is: ₹585.00.

Tranesma Plus Tablet is a pharmaceutical product that combines Tranexamic Acid and Pine Bark Extract for effective treatment of bleeding disorders and promoting cardiovascular health.

SKU: 57452 Categories: ,

Description

Tranesma Plus Tablet is a pharmaceutical product that combines Tranexamic Acid and Pine Bark Extract. Tranexamic Acid is a synthetic derivative of the amino acid lysine, which helps in the prevention and treatment of excessive bleeding by stopping the breakdown of blood clots. Pine Bark Extract, on the other hand, is a natural plant extract rich in antioxidants that promote overall health and well-being.

This combination medication is primarily used for the treatment of various ailments related to bleeding disorders. It is commonly prescribed for patients with heavy menstrual bleeding, especially in cases where other treatments have been ineffective. Tranesma Plus Tablet is also used to manage bleeding in patients with uterine fibroids, endometriosis, and post-surgical bleeding.

The mechanism of action of Tranexamic Acid involves its ability to inhibit the activation of plasmin, an enzyme responsible for breaking down blood clots. By preventing excessive clot breakdown, Tranexamic Acid helps in reducing bleeding and promotes clot stability. Pine Bark Extract, on the other hand, supports the treatment process by providing antioxidant properties that protect blood vessels and promote healing.

In conclusion, Tranesma Plus Tablet is a combination medication that offers a synergistic effect in managing bleeding disorders. It delivers the benefits of Tranexamic Acid and Pine Bark Extract to effectively reduce excessive bleeding and support the healing process. As with any medication, it is essential to consult a healthcare professional for proper diagnosis, dosage, and guidance regarding the use of Tranesma Plus Tablet.

Additional information

Weight 31 g
Marketed by

Composition

Dosage form

TABLET

Prescription

REQUIRED

Therapeutic use

COAGULANTS